Delaware | 1-16789 | 04-3565120 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 9.01. | Financial Statements and Exhibits. |
Exhibit No. | Description | |||
5.1 | Opinion of Jay McNamara, Esq., Senior Counsel, Corporate & Finance, of the Company |
|||
23.1 | Consent of Jay McNamara, Esq., Senior Counsel, Corporate & Finance, of the
Company (included in Exhibit 5.1) |
INVERNESS MEDICAL INNOVATIONS, INC. |
||||
Date: July 10, 2009 | By: | /s/ Jay McNamara | ||
Jay McNamara | ||||
Senior Counsel, Corporate & Finance |